The infection surveillance solutions market is set to reach US$ 934.7 Mn in 2026 from US$ 330.7 Mn in 2017 projecting excellent growth at a CAGR of 12.4% from 2018 to 2026. As per the latest research citing provided by World Health Organization (WHO), in the near future glooming threat of hospital acquired infection and rampant growth in antibiotic resistance by microbes will result in increased mortality worldwide. There is need to monitor and supervise infectious disease in real time mode.

"Provision of real time surveillance and rampant growth in the IT-healthcare industry drive the software market growth"

Software solutions are leading the product segment for infection surveillance solutions market. The major parameters that influence its growth are its ability to provide real time surveillance of infectious disease and rampant growth in IT-healthcare industry. Web based solutions are gaining immense popularity owing to availability in different configurations and immediate return on initial investment. On-premise software solutions are feasible in hospitals owing to low maintenance cost incurred and low subscription fee. Services segment will growth at a steady pace during the forecast period owing to entry of large number of market participants willing to provide outsourcing solutions related to infection surveillance. 

"Prolonged use of catheters and increasing number of patients with suppressed immune system drive the urinary tract infection market growth"

Urinary tract infection are reigning the type segment for infection surveillance solutions market. Increasing number of patients suffering with suppressed immune system and prolonged use of catheters drive the market growth for urinary tract infection. It is more susceptible in the women population in comparison to men. Others segment comprises of infections caused by pneumonia causing microbes and methicillin resistant staphylococcus aureus bacteria. They will register growth at a rapid pace on account of significant rise in hospital acquired infections worldwide. 

"Increasing number of inbound patients and significant rise in the number of surgeries performed drive the hospitals market growth"

In the present scenario hospitals are dominating the end-use segment for infection surveillance solutions market. The key factors that determine its outstanding growth are increasing number of inbound patients and rise in the number of surgeries performed. Lon term care centers will witness fast growth during the forecast period from 2018 to 2026, owing to its ability to antimicrobial resistance infection and increasing outbound patients due to low healthcare cost incurred. 

"Rising prevalence of hospital acquired infection (HAI) and existence of excellent healthcare framework drive the market growth in North America"

Currently North America holds 35% share in the regional segment for global infection surveillance solutions market. The important parameters that are responsible for the excellent market growth in North America are existence of excellent healthcare framework and rising prevalence of hospital acquired infection. Presence of pioneering IT-healthcare companies specializing in providing infection surveillance solutions such as Truven Health Analytics, Becton Dickinson & Company and Baxter International, Inc. etc. further consolidate the market growth in North America. Europe is the second largest regional market accounting for 30% share owing to proactive government policy in fighting infectious disease and enhanced funding in the research and development segment to counteract microbial resistance issue. Asia Pacific represents 20% market share and will be registering steady growth on account of presence of large patient pool suffering with hospital acquired infection and rising public health awareness regarding infectious disease.

IT-healthcare companies pioneering in providing infection surveillance solutions are Becton Dickinson and Company, Deb Group, Ltd., Gojo Industries, Inc., Baxter International, Inc., Truven Health Analytics, Hygreen, Inc., Premier, Inc., Atlas Medical Software, RL Solutions and Wolters Kluwer N.V.

Historical & Forecast Period

This study report represents analysis of each segment from 2023 to 2033 considering 2024 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2025 to 2033.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Infection Surveillance Solutions market are as follows:

• Research and development budgets of manufacturers and government spending
• Revenues of key companies in the market segment
• Number of end users and consumption volume, price and value.
• Geographical revenues generate by countries considered in the report
• Micro and macro environment factors that are currently influencing the Infection Surveillance Solutions market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Key questions answered in this report

• What are the key micro and macro environmental factors that are impacting the growth of Infection Surveillance Solutions market?
• What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
• Estimated forecast and market projections up to 2033.
• Which segment accounts for the fastest CAGR during the forecast period?
• Which market segment holds a larger market share and why?
• Are low and middle-income economies investing in the Infection Surveillance Solutions market?
• Which is the largest regional market for Infection Surveillance Solutions market?
• What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
• Which are the key trends driving Infection Surveillance Solutions market growth?
• Who are the key competitors and what are their key strategies to enhance their market presence in the Infection Surveillance Solutions market worldwide?